This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Siemens Demonstrates Agenda 2013 Resolve With Works-in-Progress Imaging Systems At RSNA 2012

At the 98 th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), from November 25 to 30 in Chicago, Siemens Healthcare (Booth #831, East Building/Lakeside Center at McCormick Place, Hall D) demonstrates its continued commitment to its Agenda 2013 global initiative by previewing several works-in-progress imaging systems. The new offerings illustrate the company’s innovative capacity and steadfast competitiveness in today’s changing market environment.

Siemens’ works-in-progress systems include cutting-edge technologies in the areas of magnetic resonance imaging (MRI) and radiography. Each system embodies the key tenets of Siemens’ Agenda 2013 initiative – a two-year program launched by the Healthcare Sector in November 2011 that targets innovation, regional presence, competitiveness, and the development of the company’s human resources.

Siemens’ works-in-progress imaging systems include:

  • MAGNETOM Prisma, a 3 Tesla MRI system designed with a significantly higher signal-to-noise ratio to tackle demanding clinical and research challenges.
  • Cios Alpha, a mobile C-arm system designed with greater power output and a larger field of view in the operating room (OR) than conventional C-arms.
  • MAGNETOM Essenza with Siemens’ MRI workflow solution Dot (Day optimizing throughput), which helps enhance productivity in MR scanning.
  • MAGNETOM Trio, Verio, and Avanto upgrades with Siemens’ MR workflow solution Dot (Day optimizing throughput), which helps enhance productivity in MR scanning, as well as Tim (Total imaging matrix) 4G – the latest generation of Siemens’ integrated coil technology.
  • syngo.via WebViewer VA11, which is intended to perform diagnostic reading directly on the iPad as well as provide access to images from computed and digital radiography (CR and DR), positron emission tomography (PET), and PET/computed tomography (CT) devices. 1

The products mentioned here are currently under development and are not for sale in the U.S. Their future availability cannot be guaranteed.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs